ARID1A-deficient bladder cancer is dependent on PI3K signaling and sensitive to EZH2 and PI3K inhibitors is a research paper published in JCI Insight (2022). On theSindex it has a DataRank of 0.628. It has been cited 65 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.628
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →U.S. Department of Veterans Affairs
Grant: Research Development Award
U.S. Department of Veterans Affairs
Grant: # 1I01 BX003840
U.S. Department of Defense
Grant: W81XWH1910588
U.S. Department of Defense
Grant: 1 U54 CA233306
NCI NIH HHS
Grant: U54 CA233306
NCI NIH HHS
Grant: U54 CA118948
BLRD VA
Grant: I01 BX003840
FWCI
4.76
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals